← Evidence map

ArticleBreast cancer research and treatment2017

Endocan as a prognostic biomarker of triple-negative breast cancer.

Atsunobu Sagara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27888420